Only a few reports have investigated the BRAF status of acral melanoma in comparison with primary and metastatic lesions, and these studies were limited by small sample sizes (range of 4–16 patients) [26,28,35,36]. The gene discussed is BRAF; the disease is acral lentiginous melanoma.